Breaking News Instant updates and real-time market news.

2020-05-01 07:36:08 LIND Lindblad Expeditions $6.68 / +0.18 (+2.77%) 07:36 05/01/20 05/01 07:36 05/01/20 07:36	Lindblad Expeditions experiences 'substantial impact' from COVID-19 The company was off to a strong start to the year with Lindblad segment bookings at the end of February up 25% for the full year 2020 as compared to the same point a year ago for 2019 and we had sold 88% of our original projected guest ticket revenues for the year. Since that point, the company has experienced a substantial impact from the COVID-19 virus including elevated cancellations and softness in near-term demand. Lindblad segment bookings for travel in 2020 are now 27% below the same point a year ago for 2019 due primarily to the cancelled and rescheduled voyages, as well as cancellations for travel later this year. The company does still have substantial advanced bookings for future travel in 2020, including 8% more bookings for the second half of 2020 as compared with the second half of 2019 as of the same date a year ago. Additionally, the Company continues to see new bookings for travel in 2020, 2021 and 2022, including over $15M since March 1, and we are receiving deposits and final payments for future travel. For 2020 voyages that have been cancelled or rescheduled, the company is offering future travel credits with incremental value or full refunds to its fully paid guests. As of April 24th, the majority of guests have opted for future travel credits.	01 May
LIND Lindblad Expeditions $6.68 / +0.18 (+2.77%) 04/28/20 Stifel Lindblad demand should return faster than 'normal' cruises, says Stifel 04/22/20 Deutsche Bank Lindblad Expeditions price target lowered to $7 from $16 at Deutsche Bank 04/13/20 Sidoti Lindblad Expeditions downgraded to Neutral from Buy at Sidoti 03/25/20 Sidoti Lindblad Expeditions upgraded to Buy from Neutral at Sidoti

2020-05-01 07:36:08

LIND

Lindblad Expeditions

$6.68 / +0.18 (+2.77%)

07:36

05/01/20

05/01

07:36

05/01/20

07:36

Lindblad Expeditions experiences 'substantial impact' from COVID-19

The company was off to a strong start to the year with Lindblad segment bookings at the end of February up 25% for the full year 2020 as compared to the same point a year ago for 2019 and we had sold 88% of our original projected guest ticket revenues for the year. Since that point, the company has experienced a substantial impact from the COVID-19 virus including elevated cancellations and softness in near-term demand. Lindblad segment bookings for travel in 2020 are now 27% below the same point a year ago for 2019 due primarily to the cancelled and rescheduled voyages, as well as cancellations for travel later this year. The company does still have substantial advanced bookings for future travel in 2020, including 8% more bookings for the second half of 2020 as compared with the second half of 2019 as of the same date a year ago. Additionally, the Company continues to see new bookings for travel in 2020, 2021 and 2022, including over $15M since March 1, and we are receiving deposits and final payments for future travel. For 2020 voyages that have been cancelled or rescheduled, the company is offering future travel credits with incremental value or full refunds to its fully paid guests. As of April 24th, the majority of guests have opted for future travel credits.

01
May

LIND Lindblad Expeditions

$6.68 / +0.18 (+2.77%)

04/28/20 Stifel: Lindblad demand should return faster than 'normal' cruises, says Stifel

04/22/20 Deutsche Bank: Lindblad Expeditions price target lowered to $7 from $16 at Deutsche Bank

04/13/20 Sidoti: Lindblad Expeditions downgraded to Neutral from Buy at Sidoti

03/25/20 Sidoti: Lindblad Expeditions upgraded to Buy from Neutral at Sidoti

TODAY'S FREE FLY STORIES

Conference/Events	Jefferies software/Internet analyst to hold analyst/industry conference call » 09:25 03/02/21 03/02 09:25 03/02/21 09:25 MSTR MicroStrategy $783.81 / +37.31 (+5.00%) , HLT Hilton $123.73 / -0.04 (-0.03%) Software & Internet… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSTR HLT MSTR MicroStrategy $783.81 / +37.31 (+5.00%) 03/01/21 MicroStrategy buys 328 additional bitcoins for $15M, now holds 90,859 02/24/21 MicroStrategy purchases additional 19,452 bitcoins for $1.03B in cash 02/19/21 MicroStrategy to use $1.03B estimated proceeds from notes sale to buy bitcoin 01/07/21 MicroStrategy jumps 8% to $519.64 as bitcoin tops $40,000 for first time HLT Hilton $123.73 / -0.04 (-0.03%) 02/17/21 Hilton saw meaningful step-up in new group demand in January 02/17/21 Hilton sees demand looking a lot like 2017, 2018 in 3-4 years 02/17/21 Hilton: Overall trends in Q1 so far 'similar' to Q4 02/17/21 Hilton: Overall demand remains muted MSTR HLT MSTR MicroStrategy $783.81 / +37.31 (+5.00%) 01/29/21 Citi MicroStrategy price target raised to $325 from $250 at Citi 01/13/21 Citi Elastic price target raised to $190 from $160 at Citi 12/08/20 Fly Intel: Top five analyst downgrades 12/08/20 Citi Citi downgrades MicroStrategy to Sell on 'overextended' rally, bitcoin focus HLT Hilton $123.73 / -0.04 (-0.03%) 02/22/21 Evercore ISI Hilton price target raised to $123 from $100 at Evercore ISI 02/18/21 Truist Hilton price target raised to $106 from $98 at Truist 02/18/21 Deutsche Bank Hilton price target raised to $104 from $85 at Deutsche Bank 02/18/21 Macquarie Hilton price target raised to $108 from $86 at Macquarie MSTR HLT MSTR MicroStrategy $783.81 / +37.31 (+5.00%) 10/27/20 MicroStrategy reports Q3 EPS ex-items $2.06, consensus 93c HLT Hilton $123.73 / -0.04 (-0.03%) 02/17/21 Hilton reports Q4 adjusted EPS (10c), consensus 3c 02/16/21 Notable companies reporting before tomorrow's open 02/16/21 Notable companies reporting before tomorrow's open 11/04/20 Hilton reports Q3 adjusted EPS 6c, consensus (2c) MSTR HLT MSTR MicroStrategy $783.81 / +37.31 (+5.00%) 11/24/20 Citron puts $700 target on MicroStrategy, says best way to play bitcoin 11/24/20 Citron puts $700 price target MicroStrategy shares 11/24/20 MicroStrategy best way to own bitcoin in stock market, Citron says HLT Hilton $123.73 / -0.04 (-0.03%) 02/06/21 Hilton shares primed for post-pandemic upside, Barron's says 09/03/20 Hilton Times Square set to shutter, 200 jobs to be cut, WSJ reports MSTR HLT MSTR MicroStrategy $783.81 / +37.31 (+5.00%) 02/26/21 The Intersection: Crypto and Wall Street This Week 02/19/21 The Intersection: Crypto and Wall Street This Week 01/13/21 Citi says sell Palantir on deceleration in growth, upcoming lockup expiry 12/11/20 The Intersection: Crypto and Wall Street This Week HLT Hilton $123.73 / -0.04 (-0.03%) 02/17/21 Fly Intel: Pre-market Movers 12/15/20 Wells Fargo upgrade, Dick's Sporting initiation among top calls on Wall Street 11/11/20 Hilton upgrade, AIG downgrade among today's top calls on Wall Street 11/04/20 Fly Intel: Pre-market Movers 10:00 Today Software & Internet MSTR HLT MSTR MicroStrategy $783.81 / +37.31 (+5.00%) 01/28/21 MicroStrategy options imply 18.6% move in share price post-earnings HLT Hilton $123.73 / -0.04 (-0.03%) 01/22/21 Hilton put volume heavy and directionally bearish 10/28/20 Hilton put volume heavy and directionally bearish 10/22/20 Hilton call volume above normal and directionally bullish 10/21/20 Hilton call volume above normal and directionally bullish
Recommendations	Logitech price target raised to $135 from $119 at DA Davidson » 09:24 03/02/21 03/02 09:24 03/02/21 09:24 LOGI Logitech $107.43 / -0.59 (-0.55%) DA Davidson analyst Tom… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LOGI Logitech $107.43 / -0.59 (-0.55%) 01/19/21 Logitech CEO: We're going to be right in the center of how people work 01/18/21 Logitech does not expect level of margin expansion to sustain 11/15/20 Fly Intel: Top five weekend stock stories 10/20/20 Logitech CEO: It was a great quarter LOGI Logitech $107.43 / -0.59 (-0.55%) 02/22/21 UBS Logitech price target raised to CHF 108 from CHF 90 at UBS 02/10/21 DA Davidson Corsair Gaming price target raised to $52 from $33 at DA Davidson 01/21/21 UBS Logitech price target raised to CHF 90 from CHF 74 at UBS 01/20/21 Citi Logitech price target raised to $130 from $110 at Citi LOGI Logitech $107.43 / -0.59 (-0.55%) 03/01/21 Logitech sees FY22 revenue flat +/- 5%, consensus $4.47B 03/01/21 Logitech raises FY21 revenue view to up 63% from up 57%-60%, consensus $4.8B 01/18/21 Logitech raises FY21 sales growth outlook to 57%-60% from 35%-40% 01/18/21 Logitech reports Q3 EPS $2.45, consensus $1.02 LOGI Logitech $107.43 / -0.59 (-0.55%) 11/14/20 Logitech business already booming before COVID, Barron's says 10/05/20 Apple ceases sale of rival earphones, speakers, Bloomberg reports 10/05/20 Apple ceases sale of rival earphones, speakers, Bloomberg reports 09/26/20 TVs getting left behind as videoconferencing booms, Barron's says LOGI Logitech $107.43 / -0.59 (-0.55%) 03/01/21 Fly Intel: Pre-market Movers 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/06/20 Fly Intel: Wall Street's top stories for Tuesday LOGI Logitech $107.43 / -0.59 (-0.55%) 01/05/21 Largest borrow rate increases among liquid names 12/24/20 Largest borrow rate increases among liquid names 11/09/20 Logitech put volume heavy and directionally bearish 10/28/20 Logitech put volume heavy and directionally bearish
Hot Stocks	Upland Software acquires BlueVenn for $51.9M » 09:22 03/02/21 03/02 09:22 03/02/21 09:22 UPLD Upland Software $50.40 / +0.75 (+1.51%) Upland Software announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events UPLD Upland Software $50.40 / +0.75 (+1.51%) 02/04/21 Upland Software CEO sells 20.7K shares, CFO sells 33.7K shares 01/20/21 Upland Software buys Second Street Media for $25.4M, sees immediate accretion UPLD Upland Software $50.40 / +0.75 (+1.51%) 02/25/21 Craig-Hallum Upland Software price target raised to $64 from $29 at Craig-Hallum 01/21/21 Canaccord Upland Software price target raised to $57 from $52 at Canaccord 01/15/21 Credit Suisse Upland Software assumed with an Outperform at Credit Suisse 12/28/20 Needham Needham names Anaplan top pick for 2021, boosts target to $95 UPLD Upland Software $50.40 / +0.75 (+1.51%) 02/24/21 Upland Software sees FY21 revenue $288.6M-$300.6M, consensus $294.35M 02/24/21 Upland Software reports Q4 adjusted EPS 61c, consensus 45c 02/24/21 Upland Software sees Q1 revenue $70.6M-$74.6M, consensus $71.49M 11/05/20 Upland Software sees Q4 adj. EBITDA $23.2M-$25.2M 12 Aug UPLD Upland Software $50.40 / +0.75 (+1.51%) 11/05/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference
Conference/Events	Evercore ISI to hold a virtual conference » 09:21 03/02/21 03/02 09:21 03/02/21 09:21 PH Parker-Hannifin $297.51 / +10.49 (+3.65%) , CAT Caterpillar $219.76 / +3.61 (+1.67%) , CMI Cummins $263.13 / +9.37 (+3.69%) , VNT Vontier $32.27 / +0.78 (+2.48%) , GTES Gates Industrial $15.48 / +0.48 (+3.20%) , TKR Timken $81.49 / +2.98 (+3.80%) Industrial Virtual… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PH CAT CMI VNT GTES TKR PH Parker-Hannifin $297.51 / +10.49 (+3.65%) 02/04/21 Parker-Hannifin resumes share repurchase program 11/10/20 Parker-Hannifin director Joseph Scaminace sells almost $1.3M in company shares 11/02/20 Parker-Hannifin CFO Catherine Suever to retire 11/01/20 Fly Intel: Top five weekend stock stories CAT Caterpillar $219.76 / +3.61 (+1.67%) 02/25/21 Caterpillar elects Gerald Johnson to board of directors 02/02/21 Caterpillar completes acquisition of Weir Oil & Gas, launches SPM Oil & Gas 01/29/21 Caterpillar says sees strength in base metals mining 01/29/21 Caterpillar says 'hard to quantify' improvement in 2021 vs. 2020 CMI Cummins $263.13 / +9.37 (+3.69%) 03/01/21 Cummins announces Nicole Lamb-Hale to be be General Counsel 02/24/21 EU commercial vehicle registrations down 7.2% in January 02/23/21 Daimler Truck, Cummins to establish partnership for medium duty engine systems 02/23/21 Shyft Group unit to produce new options in Isuzu's commercial truck lineup VNT Vontier $32.27 / +0.78 (+2.48%) 10/09/20 Vontier falls -14.2% 10/09/20 Vontier falls -10.6% 10/09/20 Vontier completes separation from Fortive 10/09/20 Vontier to replace Noble Energy in S&P 500 at open on 10/9 GTES Gates Industrial $15.48 / +0.48 (+3.20%) 10/13/20 Gates Industrial rises 5.5% 09/15/20 Gates Industrial rises 10.1% TKR Timken $81.49 / +2.98 (+3.80%) 02/16/21 Timken's Philadelphia Gear receives $100M supply contract from U.S. Navy 02/12/21 Timken board approves stock buyback program for up to 10M shares 12/18/20 Timken starts production at new facility in San Jose Iturbide, Mexico 12/08/20 Timken announces $75M in capital investments through early 2022 PH CAT CMI VNT GTES TKR PH Parker-Hannifin $297.51 / +10.49 (+3.65%) 02/22/21 Vertical Research Parker-Hannifin upgraded to Buy from Hold at Vertical Research 02/05/21 BMO Capital Parker-Hannifin price target raised to $350 from $320 at BMO Capital 02/05/21 Stifel Parker-Hannifin price target raised to $343 from $320 at Stifel 02/04/21 Parker-Hannifin guidance 'clear evidence' of high expectations, says Stifel CAT Caterpillar $219.76 / +3.61 (+1.67%) 02/25/21 JPMorgan Caterpillar price target raised to $237 from $205 at JPMorgan 02/10/21 Baird Baird remains bullish on Caterpillar, sees positive read through from Finning Q4 02/01/21 BMO Capital Caterpillar price target raised to $190 from $135 at BMO Capital 02/01/21 Credit Suisse Caterpillar price target raised to $235 from $228 at Credit Suisse CMI Cummins $263.13 / +9.37 (+3.69%) 02/11/21 Argus Cummins price target raised to $281 from $246 at Argus 02/08/21 Craig-Hallum Clean Energy price target raised to $25 from $12 at Craig-Hallum 02/08/21 Craig-Hallum Westport target raised to $24 following Amazon truck order, says Craig-Hallum 02/08/21 Citi Cummins price target raised to $265 from $260 at Citi VNT Vontier $32.27 / +0.78 (+2.48%) 02/25/21 Fly Intel: Top five analyst initiations 02/25/21 BofA Vontier initiated with a Buy at BofA 02/17/21 Morgan Stanley Fortive downgraded to Equal Weight at Morgan Stanley after re-rating 12/15/20 Argus Vontier initiated with a Hold at Argus GTES Gates Industrial $15.48 / +0.48 (+3.20%) 02/22/21 RBC Capital RBC upgrades Gates Industrial to Outperform on positive earnings inflection 02/22/21 RBC Capital Gates Industrial upgraded to Outperform from Sector Perform at RBC Capital 02/09/21 Barclays Gates Industrial price target raised to $18 from $16 at Barclays 02/09/21 Citi Gates Industrial price target raised to $22 from $18 at Citi TKR Timken $81.49 / +2.98 (+3.80%) 02/16/21 Evercore ISI Timken downgraded to In Line from Outperform at Evercore ISI 02/16/21 Evercore ISI Terex upgraded to Outperform from In Line at Evercore ISI 01/20/21 Vertical Research Timken initiated with a Hold at Vertical Research 01/15/21 Jefferies Timken price target raised to $100 from $74 at Jefferies PH CAT CMI VNT GTES TKR PH Parker-Hannifin $297.51 / +10.49 (+3.65%) 02/04/21 Parker-Hannifin raises 2021 adjusted EPS view $13.65-$14.15, consensus $12.39 02/04/21 Parker-Hannifin reports Q2 adjusted EPS $3.44, consensus $2.60 11/05/20 Parker-Hannifin raises FY21 adj. EPS view $11.70-$12.30, consensus $10.98 11/05/20 Parker-Hannifin reports Q1 adj. EPS $3.07, consensus $2.34 CAT Caterpillar $219.76 / +3.61 (+1.67%) 01/29/21 Caterpillar reports Q4 adjusted EPS $2.12, consensus $1.49 01/28/21 Notable companies reporting before tomorrow's open 01/28/21 Notable companies reporting before tomorrow's open 10/27/20 Caterpillar says not providing FY21 guidance CMI Cummins $263.13 / +9.37 (+3.69%) 02/04/21 Cummins sees FY21 revenue up up 8%-12%, consensus $21.67B 02/04/21 Cummins sees FY21 revenue up up 8%-12%, consensus $21.67B 02/04/21 Cummins sees FY21 revenue up up 8%-12%, consensus $21.67B 02/04/21 Cummins reports Q4 EPS $3.36, consensus $2.80 VNT Vontier $32.27 / +0.78 (+2.48%) 02/11/21 Vontier sees FY21 adjusted EPS $2.35-$2.45, consensus $2.44 02/11/21 Vontier sees Q1 adjusted EPS 52c-55c, consensus 53c 02/11/21 Vontier reports Q4 adjusted EPS 87c, consensus 85c 10/29/20 Vontier sees Q4 core revenue growth in mid-single digits, consensus $790.84M GTES Gates Industrial $15.48 / +0.48 (+3.20%) 02/08/21 Gates Industrial sees Q1 revenue $810M-$840M, consensus $765.68M 02/08/21 Gates Industrial sees FY21 revenue up 9%-14% from previous year 02/08/21 Gates Industrial reports Q4 adjusted EPS 20c, consensus 19c 11/03/20 Gates Industrial sees FY20 CapEx $70M TKR Timken $81.49 / +2.98 (+3.80%) 02/04/21 Timken sees FY21 adjusted EPS $4.70-$5.10, consensus $4.89 02/04/21 Timken reports Q4 adjusted EPS 84c, consensus 93c 10/29/20 Timken reports Q3 EPS $1.13, consensus 90c 26 Feb 14 Jan PH CAT CMI TKR PH Parker-Hannifin $297.51 / +10.49 (+3.65%) 10/31/20 Littelfuse among stocks to watch in recovery similar to China, Barron's says CAT Caterpillar $219.76 / +3.61 (+1.67%) 11/18/20 DOJ agents told to halt further action in Caterpillar case in 2018, Reuters says 09/03/20 Caterpillar added to Hedgeye best ideas long list, Bloomberg says CMI Cummins $263.13 / +9.37 (+3.69%) 02/05/21 Amazon orders over 1,000 natural gas truck engines, Reuters reports TKR Timken $81.49 / +2.98 (+3.80%) 11/19/20 ABB unit draws interest from industry suitors, Reuters reports PH CAT CMI GTES PH Parker-Hannifin $297.51 / +10.49 (+3.65%) 11/05/20 Fly Intel: Pre-market Movers CAT Caterpillar $219.76 / +3.61 (+1.67%) 01/29/21 Fly Intel: Pre-market Movers 12/30/20 AstraZeneca upgrade, Spotify target change among top calls on Wall Street 10/27/20 Fly Intel: Wall Street's top stories for Tuesday 10/27/20 Fly Intel: Wall Street's top stories at midday CMI Cummins $263.13 / +9.37 (+3.69%) 02/08/21 Fly Intel: Wall Street's top stories for Monday 02/08/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Fly Intel: Pre-market Movers GTES Gates Industrial $15.48 / +0.48 (+3.20%) 02/23/21 Fly Intel: After-Hours Movers 00:00 Today Industrial Virtual Conference 2021 03/04/21 Timken PH CAT VNT PH Parker-Hannifin $297.51 / +10.49 (+3.65%) 11/05/20 Early notable gainers among liquid option names on November 5th CAT Caterpillar $219.76 / +3.61 (+1.67%) 02/24/21 Caterpillar call volume above normal and directionally bullish 12/30/20 Caterpillar call volume above normal and directionally bullish 12/30/20 Unusually active option classes on open December 30th 10/27/20 Unusually active option classes on open October 27th VNT Vontier $32.27 / +0.78 (+2.48%) 10/21/20 Eleven new option listings and one option delisting on October 21st
Recommendations	Nielsen price target raised to $26 from $20 at Truist » 09:20 03/02/21 03/02 09:20 03/02/21 09:20 NLSN Nielsen $23.15 / +0.73 (+3.26%) Truist analyst Matthew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NLSN Nielsen $23.15 / +0.73 (+3.26%) 03/01/21 Roku to acquire Nielsen's video advertising business 02/25/21 Twitter exploring 'super follows,' users able to subscribe for exclusive content 02/16/21 Elliott buys Evergy, exits eBay in Q4 01/12/21 Nielsen begins tracking premium theatrical films distributed via streaming NLSN Nielsen $23.15 / +0.73 (+3.26%) 03/01/21 Truist Nielsen price target raised to $26 from $20 at Truist 01/28/21 Citi Nielsen price target raised to $27 from $22 at Citi 11/03/20 Deutsche Bank Nielsen price target lowered to $18 from $22 at Deutsche Bank 08/25/20 Truist Nielsen price target lowered to $20 from $23 at Truist NLSN Nielsen $23.15 / +0.73 (+3.26%) 02/25/21 Nielsen sees FY21 adjusted EPS $1.43-$1.54, consensus $1.66 02/25/21 Nielsen reports Q4 adjusted EPS 53c, consensus 46c 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open NLSN Nielsen $23.15 / +0.73 (+3.26%) 10/27/20 Nielsen in talks with PE group about $2.9B sale of consumer goods unit, FT says NLSN Nielsen $23.15 / +0.73 (+3.26%) 03/01/21 Fly Intel: After-Hours Movers 11/02/20 Fly Intel: Wall Street's top stories for Monday 11/02/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: Pre-market Movers NLSN Nielsen $23.15 / +0.73 (+3.26%) 12/04/20 Unusual call flow in option market yesterday 12/03/20 Bulls tune in to calls on Nielson Holdings 11/02/20 Early notable gainers among liquid option names on November 2nd 09/02/20 Early notable gainers among liquid option names on September 2nd

Syndicate	Twitter prices $1.25B convertible senior notes offering » 09:19 03/02/21 03/02 09:19 03/02/21 09:19 TWTR Twitter $77.66 / +0.58 (+0.75%) Twitter announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TWTR Twitter $77.66 / +0.58 (+0.75%) 03/01/21 Twitter introducing 'strike system' to combat COVID-19 vaccine misinformation 02/25/21 Twitter says 'Super Follows' expected later this year 02/25/21 Twitter sees more personalization 'a win-win' for customers, advertisers 02/25/21 Twitter considering Fleets monetization, diversifying revenue beyond ads TWTR Twitter $77.66 / +0.58 (+0.75%) 03/01/21 Fly Intel: Top five analyst upgrades 03/01/21 Cleveland Research Twitter upgraded to Buy on improved 2021 outlook at Cleveland Research 03/01/21 Cleveland Research Twitter upgraded to Buy from Neutral at Cleveland Research 02/26/21 Stifel Twitter price target raised to $70 from $60 at Stifel TWTR Twitter $77.66 / +0.58 (+0.75%) 02/25/21 Twitter announces three long-term goals, aims to double sales in 2023 02/09/21 Twitter sees Q1 revenue $940M-$1.04B, consensus $965.14M 02/09/21 Twitter reports Q4 adjusted EPS 38c, consensus 31c 02/09/21 Notable companies reporting after market close TWTR Twitter $77.66 / +0.58 (+0.75%) 02/22/21 Twitter held talks to acquire social media startup ShareChat, TechCrunch reports 02/21/21 White House working with Facebook, Twitter to tackle anti-vaxxers, Reuters says 02/21/21 Gates says social media bans not answer to divisiveness, Bloomberg reports 02/17/21 Twitter to start testing voice DMs, Android Central says TWTR Twitter $77.66 / +0.58 (+0.75%) 03/01/21 Twitter, Wayfair upgrades among today's top calls on Wall Street 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 02/24/21 #SocialStocks: Snap shares advance following first investor day 03/17/21 Technology 04/29/21 Twitter - TWTR TWTR Twitter $77.66 / +0.58 (+0.75%) 02/26/21 Early notable gainers among liquid option names on February 26th 02/25/21 Early notable gainers among liquid option names on February 25th 02/12/21 Twitter call volume above normal and directionally bullish 02/10/21 Early notable gainers among liquid option names on February 10th
Hot Stocks	Infrastructure and Energy Alternatives secures $70M wind construction contract » 09:19 03/02/21 03/02 09:19 03/02/21 09:19 IEA Infrastructure and Energy Alternatives $17.86 / +1.19 (+7.14%) Infrastructure and Energy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events Options IEA Infrastructure and Energy Alternatives $17.86 / +1.19 (+7.14%) 01/20/21 Infrastructure and Energy Alternatives awarded $45M construction contract 01/14/21 Silicon Ranch selects Infrastructure and Energy Alternatives for solar project 01/12/21 Infrastructure and Energy Alternatives secures $100M wind construction contract 12/29/20 Infrastructure and Energy Alternatives secures 185 MW wind construction contract IEA Infrastructure and Energy Alternatives $17.86 / +1.19 (+7.14%) 11/11/20 DA Davidson Infrastructure and Energy Alternatives price target raised to $13 at DA Davidson 06/11/20 DA Davidson Infrastructure and Energy Alternatives upgraded to Buy from Neutral at DA Davidson 06/11/20 DA Davidson Infrastructure and Energy Alternatives upgraded to Buy at DA Davidson 04 Feb IEA Infrastructure and Energy Alternatives $17.86 / +1.19 (+7.14%) 11/03/20 Fly Intel: Pre-market Movers 03/09/21 Infrastructure and Energy Alternatives - IEA IEA Infrastructure and Energy Alternatives $17.86 / +1.19 (+7.14%) 11/23/20 Seven new option listings and six option delistings on November 23rd
Hot Stocks	Telos, Johnson Controls form strategic partnership » 09:18 03/02/21 03/02 09:18 03/02/21 09:18 TLS Telos $34.96 / +1.51 (+4.51%) , JCI Johnson Controls $57.20 / +1.35 (+2.42%) Telos Corporation (TLS)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TLS JCI TLS Telos $34.96 / +1.51 (+4.51%) 09:17 Today Telos partners with Omnilert on secure visual gun detection solution 02/16/21 SSA exercises first option year on contract to deploy Telos' Xacta 02/09/21 Telos selected by Philadelphia International Airport for credentialing solution 02/03/21 Telos awarded $13.5M FBI contract for enterprise risk management JCI Johnson Controls $57.20 / +1.35 (+2.42%) 02/23/21 Dana appoints Byron Foster as CCMC Officer 01/29/21 Johnson Controls sees orders 'continuing to improve' going forward 01/29/21 Johnson Controls: Many end markets showed improved sequential demand in Q1 12/08/20 Microsoft, Johnson Controls announce global collaboration TLS JCI TLS Telos $34.96 / +1.51 (+4.51%) 02/16/21 Wedbush Telos price target raised to $45 from $38 at Wedbush 01/29/21 B. Riley Securities Telos price target raised to $45 from $40 at B. Riley Securities 01/19/21 Needham Telos price target raised to $45 from $31 at Needham 01/12/21 B. Riley Securities Telos price target raised to $40 from $34.50 at B. Riley Securities JCI Johnson Controls $57.20 / +1.35 (+2.42%) 02/19/21 Barclays Johnson Controls price target raised to $56 from $42 at Barclays 02/18/21 Credit Suisse Johnson Controls price target raised to $60 from $55 at Credit Suisse 02/03/21 Credit Suisse Lennox price target lowered to $285 from $300 at Credit Suisse 01/31/21 Morgan Stanley Johnson Controls price target raised to $52 from $48 at Morgan Stanley TLS JCI TLS Telos $34.96 / +1.51 (+4.51%) 07:36 Today Telos sees Q4 revenue at $44.7M, consensus $44.47M JCI Johnson Controls $57.20 / +1.35 (+2.42%) 02/17/21 Johnson Controls raises FY21 adjusted EPS view to $2.50-$2.60 from $2.45-$2.55 01/29/21 Johnson Controls sees FY21 adjusted EPS $2.45-$2.55, consensus $2.51 01/29/21 Johnson Controls sees Q2 adjusted EPS 47c-49c, consensus 48c 01/29/21 Johnson Controls reports Q1 adjusted EPS 43c, consensus 40c 19 Nov JCI JCI Johnson Controls $57.20 / +1.35 (+2.42%) 02/10/21 Brookfield weighing IPO for battery maker Clarios this year, Bloomberg says TLS TLS Telos $34.96 / +1.51 (+4.51%) 12/23/20 Telos, Palo Alto seen among potential beneficiaries of Sunburst hack 11/22/20 Opening Day: Yatsen soars in debut, raises $617M in U.S. IPO 03/11/21 Wedbush Security Virtual Conference 03/04/21 Telos - TLS TLS TLS Telos $34.96 / +1.51 (+4.51%) 01/21/21 Eighteen new option listings and one option delisting on January 21st
Syndicate	BTCS announces $9.5M registered direct offering » 09:18 03/02/21 03/02 09:18 03/02/21 09:18 BTCS BTCS $0.00 / + (+0.00%) BTCS, Inc. announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News BTCS BTCS $0.00 / + (+0.00%) 03/01/21 BTCS expands Ethereum 2.0 staking operation to 100 nodes 02/18/21 BTCS CEO says shifting focus to more active, revenue generating operations 01/07/21 BTCS management invests $1.1M into company
Hot Stocks	Kohl's plans to refresh approximately 675 stores over the next two years 09:18 03/02/21 03/02 09:18 03/02/21 09:18 KSS Kohl's $56.95 / +1.665 (+3.01%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KSS Kohl's $56.95 / +1.665 (+3.01%) 09:03 Today Kohl's 'optimistic that brighter days are ahead' 08:56 Today Kohl's 'confident' in ability to expand operating margin to 7%-8% by 2023 08:55 Today Kohl's digital sales increased 22% in Q4 vs. last year 07:05 Today Kohl's reports Q4 adjusted EPS $2.22, consensus $1.01 KSS Kohl's $56.95 / +1.665 (+3.01%) 02/18/21 Morgan Stanley Kohl's price target raised to $40 from $27 at Morgan Stanley 02/05/21 Baird Kohl's price target raised to $58 from $48 at Baird 02/05/21 Deutsche Bank Kohl's price target raised to $55 from $51 at Deutsche Bank 02/03/21 Fly Intel: Top five analyst upgrades KSS Kohl's $56.95 / +1.665 (+3.01%) 07:09 Today Kohl's sees FY21 EPS $2.45-$2.95, consensus ($2.43) 03/01/21 Notable companies reporting before tomorrow's open 03/01/21 Notable companies reporting before tomorrow's open 02/04/21 Kohl's reports preliminary Q4 EPS $1.00-$1.05, consensus 70c KSS Kohl's $56.95 / +1.665 (+3.01%) 02/22/21 Kohl's 'rejects' activist investor group attempt in statement to CNBC 02/21/21 Nine directors nominated to Kohl's board by activist investors, WSJ reports 09/21/20 Walmart to launch private label for men's and women's clothing, CNBC reports KSS Kohl's $56.95 / +1.665 (+3.01%) 09:00 Today Fly Intel: Pre-market Movers 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers 09:00 Today Kohl's - KSS KSS Kohl's $56.95 / +1.665 (+3.01%) 01/11/21 Early notable gainers among liquid option names on January 11th 12/30/20 Early notable gainers among liquid option names on December 30th 12/18/20 Early notable gainers among liquid option names on December 18th 12/11/20 Kohl's put volume heavy and directionally bearish

Options	Overnight activity included 719 trades in SPX and 16 trades in VIX » 09:18 03/02/21 03/02 09:18 03/02/21 09:18 SPX S&P 500 $0.00 / + (+0.00%) , VIX Volatility Index S&P 500 Options $0.00 / + (+0.00%) 719 trades were executed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options Technical Analysis SPX SPX S&P 500 $0.00 / + (+0.00%) 02/01/21 Robinhood raises $3.4B to continue investing in customer growth 01/26/21 Biden announces plans for U.S. to buy 200M extra COVID-19 doses 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/11/21 Gundlach recommends owning emerging markets with deflation hedges SPX VIX SPX S&P 500 $0.00 / + (+0.00%) 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year 09/01/20 Fed's Brainard says monetary policy to pivot from stabilization to accommodation 08/17/20 Goldman Sachs Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000 VIX Volatility Index S&P 500 Options $0.00 / + (+0.00%) SPX SPX S&P 500 $0.00 / + (+0.00%) 02/23/21 S&P 500 targets FY21 EPS 3.00 to $3.20, consensus SPX SPX S&P 500 $0.00 / + (+0.00%) 02/28/21 House approves Biden's $1.9T COVID aid, Reuters reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 House set to pass $1.9T COVID-19 stimulus package, CNBC reports 02/11/21 White House secures deals for additional 200M COVID-19 vaccine doses, CNBC says SPX VIX SPX S&P 500 $0.00 / + (+0.00%) 03/01/21 Overnight activity included 1584 trades in SPX and 57 trades in VIX 02/26/21 Overnight activity included 2517 trades in SPX and 109 trades in VIX 02/25/21 Overnight activity included 1020 trades in SPX and 33 trades in VIX 02/24/21 Overnight activity included 2039 trades in SPX and 24 trades in VIX VIX Volatility Index S&P 500 Options $0.00 / + (+0.00%) 03/01/21 Closing CBOE SPX and VIX Index summary for March 1st 03/01/21 Overnight activity included 1584 trades in SPX and 57 trades in VIX 02/26/21 Closing CBOE SPX and VIX Index summary for February 26th 02/26/21 Overnight activity included 2517 trades in SPX and 109 trades in VIX SPX SPX S&P 500 $0.00 / + (+0.00%) 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/19/21 On The Fly: Weekly technical notes for S&P 500 02/12/21 On The Fly: Weekly technical notes for S&P 500 02/05/21 On The Fly: Weekly technical notes for S&P 500
Conference/Events	Credit Suisse to hold a virtual conference » 09:17 03/02/21 03/02 09:17 03/02/21 09:17 ABC AmerisourceBergen $103.12 / +1.88 (+1.86%) , AFMD Affimed N.V. $5.91 / +0.25 (+4.42%) , AMED Amedisys $254.74 / +0.61 (+0.24%) , AZN AstraZeneca $48.10 / -0.25 (-0.52%) , BNTX BioNTech $110.06 / +0.61 (+0.56%) , CSL Carlisle $148.03 / +2.725 (+1.88%) , CVAC CureVac $96.15 / +1.39 (+1.47%) , FMS Fresenius Medical $35.05 / +0.49 (+1.42%) , GLPG Galapagos $84.65 / +1.6 (+1.93%) , GLTO Galecto $10.81 / +0.5301 (+5.16%) , GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) , IVA Inventiva $16.90 / +1.9 (+12.67%) , IPSEY Ipsen $0.00 / + (+0.00%) , LNTH Lantheus $19.06 / +0.33 (+1.76%) , NOV NOV Inc. $15.65 / +0.525 (+3.47%) , NOVO Novo Group Inc $0.00 / + (+0.00%) , NVS Novartis $87.44 / +1.42 (+1.65%) , PHG Philips $55.04 / +0.54 (+0.99%) , SNY Sanofi $45.90 / +0.015 (+0.03%) , TAK Takeda Pharmaceutical $16.97 / +0.26 (+1.56%) , ZEAL Zealand Pharma $32.71 / +0.76 (+2.38%) 2021 London Global… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ABC AFMD AMED AZN BNTX CSL CVAC FMS GLPG GLTO GSK IVA IPSEY LNTH NOV NVS PHG SNY TAK ZEAL ABC AmerisourceBergen $103.12 / +1.88 (+1.86%) 01/06/21 AmerisourceBergen to acquire Alliance Healthcare from Walgreens for $6.5B 11/09/20 AmerisourceBergen names Dr. Lonie Haynes as Chief Diversity & Inclusion Office 11/06/20 AmerisourceBergen reaches agreement with CDC over pharmacy vaccine access 11/05/20 AmerisourceBergen sees FY21 CapEx ~$400M AFMD Affimed N.V. $5.91 / +0.25 (+4.42%) 02/08/21 Point72 Asset Management reports 5.0% passive stake in Affimed N.V. 02/03/21 Affimed N.V. announces pact with Roche to study AFM24/atezolizumab combo 01/07/21 Affimed N.V. provides pipeline and business update 11/19/20 Affimed announces publication of results from study of ICE with Keytruda AMED Amedisys $254.74 / +0.61 (+0.24%) 02/24/21 Amedisys promotes Christopher Gerard to COO, Scott Ginn to CFO 01/05/21 Amedisys, Option Care Health collaborate on COVID therapy access model 12/23/20 Amedisys announces up to $100M share repurchase plan AZN AstraZeneca $48.10 / -0.25 (-0.52%) 07:25 Today AstraZeneca advances mass global rollout of COVID-19 vaccine through COVAX 03/01/21 FibroGen, AstraZeneca report FDA to hold AdCom meeting to review roxadustat NDA 02/26/21 Amgen, AstraZeneca report 'positive' results from NAVIGATOR Phase 3 trial 02/24/21 ChemoCentryx appoints Tausif Butt as EVP, COO BNTX BioNTech $110.06 / +0.61 (+0.56%) 02/25/21 Pfizer, BioNTech to evaluate safety of third dose of COVID-19 vaccine 02/22/21 Amyris announces pre-clinical results for COVID RNA vaccine platform 02/19/21 Pfizer, BioNTech submit COVID-19 vaccine stability data to the FDA 02/18/21 Pfizer, BioNTech start trial to evaluate COVID-19 vaccine in pregnant women CSL Carlisle $148.03 / +2.725 (+1.88%) 02/12/21 Carlisle names Kelly P. Kamienski as Controller 02/02/21 Carlisle announces additional buyback of 5M shares of common stock CVAC CureVac $96.15 / +1.39 (+1.47%) 02/05/21 CureVac enters pact with UK Government to develop SARS-CoV-2 variant vaccine 02/04/21 CureVac expands CV8102 cancer program to advanced melanoma 02/03/21 CureVac, GSK in pact to jointly develop mRNA vaccines for COVID-19 01/07/21 Bayer signs collaboration, services agreement with CureVac for COVID-19 vaccine FMS Fresenius Medical $35.05 / +0.49 (+1.42%) 02/10/21 Model N discloses J&J agreed to transition to its Revenue Cloud for Life Science 01/19/21 CytoSorb approved in Korea for all EU approved indications GLPG Galapagos $84.65 / +1.6 (+1.93%) 02/10/21 Galapagos, Gilead discontinue Phase 3 ISABELA trials 02/10/21 Gilead, Galapagos discontinue ISABELA Phase 3 trials in IPF 01/21/21 Galapagos announces NICE recommendation for Jyseleca on NHS 12/15/20 Galapagos to assume development, manufacturing, other rights for Jyseleca GLTO Galecto $10.81 / +0.5301 (+5.16%) 01/08/21 Galecto appoints Anne Prener to board of directors 11/30/20 Galecto announces publication of GB0139 Phase 2a IPF results GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 08:04 Today Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX 02/24/21 J&J's Janssen announces submission of sNDA to FDA for expanded Cabenuva use 02/24/21 ViiV Healthcare submits sNDA to FDA for HIV treatment Cabenuva 02/22/21 Sanofi, GSK initiate Phase 2 study of COVID-19 vaccine candidate IVA Inventiva $16.90 / +1.9 (+12.67%) 01/05/21 Inventiva announces Phase 3 lanifibranor trial details 12/07/20 Inventiva announces journal publication on effect of lanifibranor in ACLD 11/10/20 Inventiva announces conclusions from phase II meeting with FDA 11/06/20 Inventiva CMO Marie-Paule Richard to retire, Michael Cooreman to succeed IPSEY Ipsen $0.00 / + (+0.00%) 07:32 Today Fusion Pharmaceuticals to acquire Ipsen's IP, assets related to IPN-1087 02/26/21 Exelixis: Ipsen receives positive CHMP opinion for CABOMETYX/OPDIVO combo 02/22/21 Ipsen to announce new data from CLARINET FORTE study at ENETS Conference 11/30/20 Ipsen announces Fast Track designation for irinotecan liposome injection LNTH Lantheus $19.06 / +0.33 (+1.76%) 03/01/21 Lantheus announces publication of PyL results from pivotal studies 01/12/21 Lantheus announces submission of DMF for NM-01 in the U.S. 12/09/20 Lantheus reports acceptance, priority review of New Drug Application for PyLTM 12/09/20 Lantheus enters strategic collaboration with Point Biopharma to use PET NOV NOV Inc. $15.65 / +0.525 (+3.47%) 01/19/21 NOV Inc. falls -6.5% 12/21/20 National Oilwell to adopt new corporate name 'NOV Inc.' 11/18/20 National Oilwell, NexTier Oilfield partner on field test of electric frac system NVS Novartis $87.44 / +1.42 (+1.65%) 03/01/21 Homology Medicines regains worldwide rights to ophthalmology program 02/17/21 Novartis announces SCD grant agreement with Bill & Melinda Gates Foundation 02/16/21 Novartis reports Entresto granted expanded indication in chronic heart failure 02/11/21 Novartis' Sandoz agrees to acquire GSK's cephalosporin antibiotics business PHG Philips $55.04 / +0.54 (+0.99%) 08:16 Today Acutus Medical appoints Duane Wilder as CCO 08:11 Today Philips partners with DiA Imaging Analysis to enhance ultrasound 05:19 Today Philips appoints Shez Partovi chief innovation and strategy officer 02/18/21 ClearPoint Neuro, Philips enter license and research agreement for Maestro SNY Sanofi $45.90 / +0.015 (+0.03%) 02/22/21 Regeneron announces third FDA approval for PD-1 inhibitor Libtayo 02/22/21 Sanofi, GSK initiate Phase 2 study of COVID-19 vaccine candidate 02/12/21 Sanofi offers to acquire Kiadis Pharma shares for EUR 5.45 per share in cash 02/12/21 Regeneron, Sanofi announce results from Libtayo comparative study published TAK Takeda Pharmaceutical $16.97 / +0.26 (+1.56%) 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/26/21 Takeda to divest type 2 diabetes portfolio to Teijin Pharma for JPY 133B 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan 02/12/21 Takeda Pharmaceutical's maribavir Phase 3 clinical trial met primary endpoint ZEAL Zealand Pharma $32.71 / +0.76 (+2.38%) 12/15/20 Zealand Pharma: Dasiglucagon did not meet primary endpoint in Phase 3 trial 12/15/20 Zealand Pharma announces data from Phase 3 dasiglucagon in CHI trial 11/20/20 Zealand Pharma increases share capital following exercise of employee warrants ABC AFMD AMED AZN BNTX CSL CVAC FMS GLPG GLTO GSK IVA IPSEY LNTH NOV NOVO NVS PHG SNY TAK ZEAL ABC AmerisourceBergen $103.12 / +1.88 (+1.86%) 02/09/21 Mizuho AmerisourceBergen price target raised to $114 from $104 at Mizuho 02/08/21 Cowen AmerisourceBergen price target raised to $150 from $145 at Cowen 02/04/21 Evercore ISI AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI 02/04/21 Evercore ISI AmerisourceBergen upgraded to Outperform from In Line at Evercore ISI AFMD Affimed N.V. $5.91 / +0.25 (+4.42%) AMED Amedisys $254.74 / +0.61 (+0.24%) 02/23/21 Benchmark Amedisys price target raised to $325 from $275 at Benchmark 02/08/21 Deutsche Bank Amedisys price target raised to $340 from $275 at Deutsche Bank 01/05/21 Truist Amedisys price target raised to $325 from $280 at Truist 11/03/20 Barclays Amedisys price target raised to $298 from $290 at Barclays AZN AstraZeneca $48.10 / -0.25 (-0.52%) 02/25/21 Fly Intel: Top five analyst upgrades 02/25/21 UBS AstraZeneca upgraded to Buy from Neutral at UBS 02/04/21 Piper Sandler Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' BNTX BioNTech $110.06 / +0.61 (+0.56%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley CSL Carlisle $148.03 / +2.725 (+1.88%) 01/26/21 Longbow Carlisle price target raised to $160 from $150 at Longbow 01/08/21 Oppenheimer Carlisle price target raised to $175 from $160 at Oppenheimer 11/13/20 Carlisle cut to Hold at Loop Capital on valuation 11/13/20 Loop Capital Carlisle downgraded to Hold from Buy at Loop Capital CVAC CureVac $96.15 / +1.39 (+1.47%) 01/07/21 Morgan Stanley CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley 12/10/20 Credit Suisse CureVac downgraded to Underperform on rising valuation at Credit Suisse 12/10/20 Credit Suisse CureVac downgraded to Underperform from Neutral at Credit Suisse 11/02/20 Piper Sandler CureVac's positive vaccine data bodes well for Arcturus's ARCT-021, says Piper FMS Fresenius Medical $35.05 / +0.49 (+1.42%) 02/26/21 JPMorgan Fresenius Medical price target raised to EUR 52.40 from EUR 51.10 at JPMorgan 02/24/21 Truist Fresenius Medical cut to Hold at Truist on more difficult operating backdrop 02/24/21 Truist Fresenius Medical downgraded to Hold from Buy at Truist 02/17/21 UBS Fresenius Medical price target lowered to EUR 72 from EUR 94 at UBS GLPG Galapagos $84.65 / +1.6 (+1.93%) 02/23/21 BofA Galapagos upgraded to Neutral from Underperform at BofA 02/23/21 BofA Galapagos upgraded to Neutral from Underperform at BofA 02/19/21 Raymond James Raymond James upgrades 'heavily discounted' Galapagos to Outperform 02/19/21 Raymond James Galapagos upgraded to Outperform from Market Perform at Raymond James GLTO Galecto $10.81 / +0.5301 (+5.16%) 11/23/20 SVB Leerink SVB Leerink bullish on Galecto, initiates with an Outperform 11/23/20 SVB Leerink Galecto initiated with an Outperform at SVB Leerink 11/23/20 Credit Suisse Galecto initiated with an Outperform at Credit Suisse 11/23/20 BofA Galecto initiated with a Buy at BofA GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 02/12/21 Morgan Stanley GlaxoSmithKline price target lowered to 1,580 GBp at Morgan Stanley 02/11/21 Berenberg GlaxoSmithKline price target lowered to 1,570 GBp from 1,720 GBp at Berenberg 02/09/21 JPMorgan GlaxoSmithKline price target lowered to 1,300 GBp from 1,500 GBp at JPMorgan 02/08/21 UBS GlaxoSmithKline price target lowered to 1,320 GBp from 1,450 GBp at UBS IVA Inventiva $16.90 / +1.9 (+12.67%) 10/13/20 Roth Capital Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation 08/17/20 H.C. Wainwright Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright 08/05/20 Fly Intel: Top five analyst initiations 08/05/20 Roth Capital Inventiva initiated with a Buy at Roth Capital IPSEY Ipsen $0.00 / + (+0.00%) 02/16/21 Barclays Ipsen price target lowered to EUR 89 from EUR 96 at Barclays 01/14/21 Societe Generale Ipsen upgraded to Buy from Hold at Societe Generale 12/08/20 Morgan Stanley Ipsen downgraded to Equal Weight from Overweight at Morgan Stanley 12/04/20 BofA Ipsen downgraded to Neutral from Buy at BofA LNTH Lantheus $19.06 / +0.33 (+1.76%) 02/01/21 Fly Intel: Top five analyst initiations 02/01/21 SVB Leerink SVB Leerink bullish on Lantheus, initiates with an Outperform 02/01/21 SVB Leerink Lantheus initiated with an Outperform at SVB Leerink 12/29/20 Credit Suisse Lantheus price target lowered to $14 from $16 at Credit Suisse NOV NOV Inc. $15.65 / +0.525 (+3.47%) 01/21/21 Susquehanna NOV Inc. price target lowered to $17 from $18 at Susquehanna 01/21/21 Wells Fargo NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo 01/21/21 Wells Fargo NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo 01/12/21 Citi NOV Inc. upgraded to Buy from Neutral at Citi NOVO Novo Group Inc $0.00 / + (+0.00%) NVS Novartis $87.44 / +1.42 (+1.65%) 03/01/21 Oppenheimer Homology Medicines loses potential source of upside, says Oppenheimer 02/02/21 Morgan Stanley Novartis price target lowered to CHF 102 from CHF 104 at Morgan Stanley 02/01/21 Truist iRhythm price target lowered to $220 from $265 at Truist 02/01/21 Cowen Novartis downgraded to Market Perform after 'tepid' guidance at Cowen PHG Philips $55.04 / +0.54 (+0.99%) 01/26/21 Credit Suisse Philips price target raised to EUR 45 from EUR 41 at Credit Suisse 01/26/21 JPMorgan Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan 01/26/21 UBS Philips price target raised to EUR 54 from EUR 51 at UBS 01/25/21 Morgan Stanley iRhythm price target raised to $288 from $227 at Morgan Stanley SNY Sanofi $45.90 / +0.015 (+0.03%) 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 02/10/21 Morgan Stanley Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley 02/05/21 Piper Sandler Piper reiterates Overweight on Kymera after Sanofi capital markets day 01/19/21 UBS Sanofi price target lowered to EUR 99 from EUR 100 at UBS TAK Takeda Pharmaceutical $16.97 / +0.26 (+1.56%) 01/29/21 Morgan Stanley Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout 12/29/20 Needham Needham names Phathom Pharmaceuticals Top Pick for 2021 12/15/20 Needham Phathom Pharmaceuticals price target raised to $55 from $45 at Needham 06/18/20 RBC Capital Neurocrine price target raised to $135 from $116 at RBC Capital ZEAL Zealand Pharma $32.71 / +0.76 (+2.38%) 03/10/20 Morgan Stanley Zealand Pharma EPS estimates cut at Morgan Stanley ABC AMED AZN CSL GLPG GLTO GSK LNTH NOV NVS PHG SNY ZEAL ABC AmerisourceBergen $103.12 / +1.88 (+1.86%) 02/04/21 AmerisourceBergen raises FY21 adjusted EPS view to $8.40-$8.60 from $8.25-$8.50 02/04/21 AmerisourceBergen reports Q1 adjusted EPS $2.18, consensus $1.94 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open AMED Amedisys $254.74 / +0.61 (+0.24%) 02/24/21 Amedisys sees FY21 adjusted EPS $6.25-$6.47, consensus $6.31 02/24/21 Amedisys reports Q4 adjusted EPS $1.49, consensus $1.47 10/28/20 Amedisys sees FY20 EPS $6.02- $6.08, consensus $4.98 10/28/20 Amedisys reports Q3 EPS $2.24, consensus $1.28 AZN AstraZeneca $48.10 / -0.25 (-0.52%) 02/11/21 AstraZeneca sees FY21 core EPS $4.75-$5.00 02/11/21 AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 11/05/20 AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year CSL Carlisle $148.03 / +2.725 (+1.88%) 02/04/21 Carlisle reports Q4 EPS $1.57, consensus $1.16 10/20/20 Carlisle reports Q3 EPS $1.87, consensus $1.68 GLPG Galapagos $84.65 / +1.6 (+1.93%) 02/18/21 Galapagos reports FY 20 EUR 530M versus EUR 886M in 2019 GLTO Galecto $10.81 / +0.5301 (+5.16%) 12/11/20 Galecto reports Q3 EPS ($55.25) vs. ($21.18) last year GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 02/03/21 GlaxoSmithKline reports Q4 adjusted EPS 23.3p vs. 24.8p a year ago 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% LNTH Lantheus $19.06 / +0.33 (+1.76%) 02/25/21 Lantheus sees Q1 EPS (3c) to 0c, consensus 2c 02/25/21 Lantheus reports Q EPS 7c, consensus 1c 11/05/20 Lantheus reports Q3 adj. EPS 4c, consensus 1c NOV NOV Inc. $15.65 / +0.525 (+3.47%) 02/04/21 NOV Inc. reports Q4 EPS (90c), consensus (19c) 01/19/21 NOV lowers Q4 revenue view to $1.33B, consensus $1.36B 10/26/20 National Oilwell reports Q3 EPS (14c), consensus (10c) NVS Novartis $87.44 / +1.42 (+1.65%) 01/26/21 Novartis sees 2021 core operating income to grow mid single digit 01/26/21 Novartis reports Q4 core EPS $1.34, consensus $1.36 11/05/20 Xoma reports Q3 EPS (10c), consensus (21c) 10/27/20 Novartis raises FY20 core operating income growth outlook PHG Philips $55.04 / +0.54 (+0.99%) 01/25/21 Philips reports Q4 adjusted EPS EUR 0.94 vs. EUR 0.83 last year 10/19/20 Philips reports Q3 adj. EPS EUR 0.60 vs. EUR 0.46 last year SNY Sanofi $45.90 / +0.015 (+0.03%) 02/05/21 Sanofi reports Q4 business EPS EUR 1.22, flat vs. last year 10/29/20 Sanofi reports Q3 business EPS EUR 1.83, up 0.5% from last year ZEAL Zealand Pharma $32.71 / +0.76 (+2.38%) 11/12/20 Zealand Pharma expects 2020 revenue for V-Go sales DKK150M-DKK175M 11/12/20 Zealand Pharma reports Q3 revenue DKK56.5M vs. DKK9.9M last year 28 Jan 13 Jan 29 Oct 14 Aug 23 Jul 10 Jul ABC AZN BNTX CVAC FMS GSK NVS PHG SNY TAK ABC AmerisourceBergen $103.12 / +1.88 (+1.86%) 11/05/20 Distributors and J&J closing in on $26B opioid settlement deal, NY Times says 09/24/20 U.S. appeals court rejects novel opioid settlement framework, Reuters says AZN AstraZeneca $48.10 / -0.25 (-0.52%) 02/28/21 AstraZeneca sells stake in Moderna for over $1B, The Times reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 Germany to receive 16M AstraZeneca Covid vaccines in Q2, Reuters reports 02/23/21 AstraZeneca: COVID-19 vaccine could receive U.S. EUA by April, Reuters says BNTX BioNTech $110.06 / +0.61 (+0.56%) 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/19/21 Pfizer to use additional capacity to boost vaccine output, Bloomberg says 02/19/21 BioNTech, Pfizer vaccine 85% effective after first dose, FT reports 02/17/21 Moderna to supply EU with another 150M vaccine doses in 2021, FT reports CVAC CureVac $96.15 / +1.39 (+1.47%) 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says 09/04/20 Germany awards grant to CureVac to accelerate vaccine development, BI reports 09/03/20 Musk praised CureVac to German Economy Minister, Reuters reports FMS Fresenius Medical $35.05 / +0.49 (+1.42%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 02/09/21 Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says NVS Novartis $87.44 / +1.42 (+1.65%) 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports PHG Philips $55.04 / +0.54 (+0.99%) 01/05/21 Philips shortlists Asian suitors in home appliance unit sale, Bloomberg says SNY Sanofi $45.90 / +0.015 (+0.03%) 02/15/21 CEO says Sanofi mRNA vaccine won't be ready this year, Bloomberg reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports TAK Takeda Pharmaceutical $16.97 / +0.26 (+1.56%) 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports ABC AMED AZN BNTX CVAC GLPG GLTO GSK IVA LNTH NOV NVS PHG SNY ABC AmerisourceBergen $103.12 / +1.88 (+1.86%) 02/04/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 01/06/21 Fly Intel: Pre-market Movers AMED Amedisys $254.74 / +0.61 (+0.24%) 02/24/21 Fly Intel: After-Hours Movers AZN AstraZeneca $48.10 / -0.25 (-0.52%) 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 02/16/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Fly Intel: Wall Street's top stories for Monday 02/08/21 Fly Intel: Wall Street's top stories at midday BNTX BioNTech $110.06 / +0.61 (+0.56%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/18/21 Fly Intel: Wall Street's top stories for Thursday 02/18/21 Fly Intel: Wall Street's top stories at midday CVAC CureVac $96.15 / +1.39 (+1.47%) 01/25/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: Pre-market Movers 11/10/20 Fly Intel: Pre-market Movers 11/02/20 Fly Intel: Pre-market Movers GLPG Galapagos $84.65 / +1.6 (+1.93%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/15/20 Fly Intel: After-Hours Movers GLTO Galecto $10.81 / +0.5301 (+5.16%) 11/01/20 Opening Day: MediaAlpha jumps 64%, Root falls flat in debut GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/17/21 Fly Intel: Pre-market Movers 02/11/21 Fly Intel: Wall Street's top stories for Thursday IVA Inventiva $16.90 / +1.9 (+12.67%) 10/19/20 Fly Intel: After-Hours Movers 10/12/20 Fly Intel: After-Hours Movers LNTH Lantheus $19.06 / +0.33 (+1.76%) 02/25/21 Fly Intel: After-Hours Movers 11/18/20 Fly Intel: After-Hours Movers NOV NOV Inc. $15.65 / +0.525 (+3.47%) 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers NVS Novartis $87.44 / +1.42 (+1.65%) 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/11/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks PHG Philips $55.04 / +0.54 (+0.99%) 01/25/21 Fly Intel: Pre-market Movers 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Wall Street's top stories at midday 10/19/20 Fly Intel: Pre-market Movers SNY Sanofi $45.90 / +0.015 (+0.03%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 00:00 Today 41st Annual Healthcare Virtual Conference 00:00 Today 2021 London Global Healthcare Virtual Conference 03/15/21 2021 Industrials Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/05/21 Inventiva - IVA 04/22/21 Carlisle - CSL 04/28/21 NOV Inc. - NOV 05/07/21 Galapagos - GLPG 03/20/21 PDUFA Date for Roxadustat--Extended Date 03/27/21 PDFUA Date for Dasiglucagon HypoPal�Rescue Pen 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease 05/18/21 PDUFA Date for Avalglucosidase Alfa 03/05/21 Zealand Pharma 03/11/21 Amedisys 03/11/21 AmerisourceBergen Corporation 05/05/21 Carlisle Companies ABC AZN BNTX CVAC GSK NOV TAK ABC AmerisourceBergen $103.12 / +1.88 (+1.86%) 01/06/21 Early notable gainers among liquid option names on January 6th 10/15/20 Early notable gainers among liquid option names on October 15th AZN AstraZeneca $48.10 / -0.25 (-0.52%) 02/24/21 AstraZeneca call volume above normal and directionally bullish 02/17/21 AstraZeneca call volume above normal and directionally bullish 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th BNTX BioNTech $110.06 / +0.61 (+0.56%) 02/17/21 Largest borrow rate increases among liquid names 01/26/21 BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names CVAC CureVac $96.15 / +1.39 (+1.47%) 12/03/20 Largest borrow rate increases among liquid names 09/29/20 Largest borrow rate increases among liquid names 09/15/20 Largest borrow rate increases among liquid names 09/11/20 Largest borrow rate increases among liquid names GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish NOV NOV Inc. $15.65 / +0.525 (+3.47%) 12/01/20 Early notable gainers among liquid option names on December 1st TAK Takeda Pharmaceutical $16.97 / +0.26 (+1.56%) 01/22/21 Takeda Pharmaceutical call volume above normal and directionally bullish
Hot Stocks	Telos partners with Omnilert on secure visual gun detection solution » 09:17 03/02/21 03/02 09:17 03/02/21 09:17 TLS Telos $34.96 / +1.51 (+4.51%) Telos Corporation and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options TLS Telos $34.96 / +1.51 (+4.51%) 02/16/21 SSA exercises first option year on contract to deploy Telos' Xacta 02/09/21 Telos selected by Philadelphia International Airport for credentialing solution 02/03/21 Telos awarded $13.5M FBI contract for enterprise risk management 01/08/21 ST Engineering announces strategic partnership with Telos TLS Telos $34.96 / +1.51 (+4.51%) 02/16/21 Wedbush Telos price target raised to $45 from $38 at Wedbush 01/29/21 B. Riley Securities Telos price target raised to $45 from $40 at B. Riley Securities 01/19/21 Needham Telos price target raised to $45 from $31 at Needham 01/12/21 B. Riley Securities Telos price target raised to $40 from $34.50 at B. Riley Securities TLS Telos $34.96 / +1.51 (+4.51%) 07:36 Today Telos sees Q4 revenue at $44.7M, consensus $44.47M 19 Nov TLS Telos $34.96 / +1.51 (+4.51%) 12/23/20 Telos, Palo Alto seen among potential beneficiaries of Sunburst hack 11/22/20 Opening Day: Yatsen soars in debut, raises $617M in U.S. IPO 03/11/21 Wedbush Security Virtual Conference 03/04/21 Telos - TLS TLS Telos $34.96 / +1.51 (+4.51%) 01/21/21 Eighteen new option listings and one option delisting on January 21st
Hot Stocks	Target says 'our business model is working as intended' » 09:16 03/02/21 03/02 09:16 03/02/21 09:16 TGT Target $186.12 / +2.54 (+1.38%) Says recent investments… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TGT Target $186.12 / +2.54 (+1.38%) 08:52 Today Target not providing FY21 guidance 'in the face of continued uncertainty' 06:38 Today Target reports Q4 digital comparable sales grew 118% 02/25/21 Target announces enhanced Apple shopping experience for customers 02/24/21 Amyris launches Pipette clean baby care brand in Target TGT Target $186.12 / +2.54 (+1.38%) 02/09/21 Jefferies Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Stifel Target upgraded to Buy from Hold at Stifel 01/14/21 DA Davidson Target price target raised to $229 from $208 at DA Davidson TGT Target $186.12 / +2.54 (+1.38%) 06:34 Today Target reports Q4 adjusted EPS $2.67, consensus $2.54 03/01/21 Notable companies reporting before tomorrow's open 03/01/21 Notable companies reporting before tomorrow's open 11/18/20 Target reports Q3 total revenue $22.63B, consensus $20.93B TGT Target $186.12 / +2.54 (+1.38%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/06/20 Chick-fil-A sues Tyson, others for poultry price-fixing, Bloomberg says 11/14/20 Targe booming during pandemic, stock still undervalued, Barron's says 10/24/20 Sprouts Farmers ready for rebound, Barron's says TGT Target $186.12 / +2.54 (+1.38%) 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Target, Estee Lauder upgrades among today's top calls on Wall Street 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 09:00 Today Target - TGT 09:00 Today Target Corporation TGT Target $186.12 / +2.54 (+1.38%) 11/19/20 Early notable gainers among liquid option names on November 19th 11/17/20 Unusually active option classes on open November 17th
Recommendations	Kodiak Sciences price target lowered to $138 from $148 at BMO Capital » 09:16 03/02/21 03/02 09:16 03/02/21 09:16 KOD Kodiak Sciences $135.07 / +5.515 (+4.26%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly KOD Kodiak Sciences $135.07 / +5.515 (+4.26%) 02/14/21 Kodiak Sciences announces data from ongoing Phase 1b study of KSI-301 11/16/20 Kodiak Sciences completes enrollment of DAZZLE study of KSI-301 10/05/20 Kodiak Sciences: First patients treated in Phase 3 Studies of KSI-301 KOD Kodiak Sciences $135.07 / +5.515 (+4.26%) 03/01/21 Roth Capital Kodiak Sciences well positioned to 'execute on all fronts,' says Roth Capital 03/01/21 Barclays Kodiak Sciences downgraded to Underweight from Equal Weight at Barclays 02/17/21 Roth Capital Kodiak Sciences downgraded to Neutral from Buy at Roth Capital 01/25/21 BMO Capital Kodiak Sciences cut to Market Perform at BMO Capital on valuation KOD Kodiak Sciences $135.07 / +5.515 (+4.26%) 03/01/21 Kodiak Sciences reports Q4 EPS (97c), consensus (80c) 11/09/20 Kodiak Sciences reports Q3 EPS (80c), consensus (67c) 18 Nov KOD Kodiak Sciences $135.07 / +5.515 (+4.26%) 11/16/20 Fly Intel: After-Hours Movers 09/14/20 Fly Insider: Karuna, DexCom among weeks notable insider trades

Periodicals	Toyota reports February U.S. sales down 5.7%, Bloomberg says 09:15 03/02/21 03/02 09:15 03/02/21 09:15 TM Toyota $149.32 / +1.385 (+0.94%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly TM Toyota $149.32 / +1.385 (+0.94%) 02/18/21 Toyota West Virginia announces $210M investment, 100 new jobs 02/17/21 EU passenger car registrations down 24.0% in January 02/16/21 Toyota to temporarily halt production at 9 factories in Japan after earthquake 02/10/21 Toyota to debut three new EVs for U.S. market in 2021 TM Toyota $149.32 / +1.385 (+0.94%) 09/14/20 Credit Suisse Toyota upgraded to Outperform from Neutral at Credit Suisse 09/08/20 Bernstein Bernstein sees Tesla's current valuation as 'mind-boggling' 07/29/20 Morgan Stanley Tesla price target raised to $1,050 from $740 at Morgan Stanley 07/28/20 Macquarie Toyota initiated with an Underperform at Macquarie TM Toyota $149.32 / +1.385 (+0.94%) 02/10/21 Toyota reports nine months EPS Y525.23 vs. Y608.73 last year 11/06/20 Toyota sees FY21 sales revenue Y26T, operating income Y1.3B 11/06/20 Toyota reports 1H EPS Y223.81 vs. Y403.51 last year TM Toyota $149.32 / +1.385 (+0.94%) 03/01/21 U.S. regulators open probe into 1.9M Toyota RAV 4 vehicles, Reuters says 02/16/21 Toyota to temporarily halt production at nine factories in Japan, Reuters says 02/03/21 Toyota aims to produce 9.2M vehicles in 2021, Nikkei reports 01/14/21 Toyota resolves DOJ probe into emissions defect reports for $180M, Reuters says TM Toyota $149.32 / +1.385 (+0.94%) 09/22/20 Tesla slips ahead of Battery Day as Musk says 'serious' output not until 2022 09/16/20 Casino stocks downgrades, Tesla target increases among top calls on Wall Street
Hot Stocks	BAE Systems gets $58M Boeing contract for LRIP of the EPAWSS by USAF » 09:15 03/02/21 03/02 09:15 03/02/21 09:15 BAESY BAE Systems $0.00 / + (+0.00%) , BA Boeing $224.41 / +12.395 (+5.85%) BAE Systems (BAESY) has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BAESY BA BAESY BAE Systems $0.00 / + (+0.00%) 02/18/21 BAE Systems gets order from the Norwegian army for more CV90s 02/17/21 BAE Systems gets contract to develop advanced military GPS receivers and chips 02/10/21 BAE Systems awarded $183.84M Navy contract modification 02/10/21 BAE Systems to supply 12 Bofors 40 Mk4 naval guns to Belgian, Dutch Navies BA Boeing $224.41 / +12.395 (+5.85%) 02/26/21 Bell-Boeing awarded $309.58M Navy contract modification 02/24/21 FAA: Pratt & Whitney engines must be inspected before flights resume 02/23/21 Spirit AeroSystems announces backlog of approximately $34B at end of Q4 02/23/21 Mesa Air signs LOI to lease additional 737-400F cargo aircraft BAESY BA BAESY BAE Systems $0.00 / + (+0.00%) 02/11/21 Deutsche Bank BAE Systems price target lowered to 660 GBp from 685 GBp at Deutsche Bank 02/11/21 Morgan Stanley BAE Systems price target raised to 647 GBp from 630 GBp at Morgan Stanley 02/10/21 Deutsche Bank BAE Systems price target lowered to 660 GBp from 685 GBp at Deutsche Bank 01/19/21 Credit Suisse BAE Systems price target lowered to 615 GBp from 645 GBp at Credit Suisse BA Boeing $224.41 / +12.395 (+5.85%) 03/01/21 Morgan Stanley Boeing price target raised to $250 from $230 at Morgan Stanley 02/19/21 Benchmark Boeing price target lowered to $270 from $290 at Benchmark 02/10/21 Deutsche Bank Airbus initiated with a Buy at Deutsche Bank 01/29/21 Fly Intel: Top five analyst upgrades Spire BA BA Boeing $224.41 / +12.395 (+5.85%) 01/27/21 Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) BAESY BA BAESY BAE Systems $0.00 / + (+0.00%) 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports BA Boeing $224.41 / +12.395 (+5.85%) 02/25/21 Boeing facing FAA fine, 'much bigger 787 repair bill,' Reuters says 02/25/21 Boeing facing FAA fine, 'much bigger 787 repair bill,' Reuters says 02/25/21 DOT: FAA must strengthen oversight of aircraft safety, WSJ reports 02/25/21 Boeing had planned to replace 777 engine covers before failures, WSJ reports BAESY BA BAESY BAE Systems $0.00 / + (+0.00%) 01/02/21 Week in review: How Trump's policies moved stocks 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Week in review: How Trump's policies moved stocks BA Boeing $224.41 / +12.395 (+5.85%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers 01/29/21 Boeing double upgrade among today's top calls on Wall Street 04/20/21 Boeing Co. BA BA Boeing $224.41 / +12.395 (+5.85%) 03/01/21 Early notable gainers among liquid option names on March 1st 03/01/21 Unusually active option classes on open March 1st 02/24/21 Boeing call volume above normal and directionally bullish 02/16/21 Boeing call volume above normal and directionally bullish
General news	U.S. chain store sales surged to a 4.6% y/y clip in the week ended February 27 » 09:15 03/02/21 03/02 09:15 03/02/21 09:15 U.S. chain store sales… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Crypto miners not driving outsized gaming GPU revenues, says Jefferies » 09:13 03/02/21 03/02 09:13 03/02/21 09:13 NVDA Nvidia $553.84 / +5.03 (+0.92%) , AMD AMD $86.41 / +1.9 (+2.25%) Jefferies analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NVDA AMD NVDA Nvidia $553.84 / +5.03 (+0.92%) 02/24/21 Nvidia says cryptocurrencies have showed signs of staying power 02/24/21 Nvidia rises 3% to $596.63 after A4 earning beat 02/18/21 Nvidia introduces Cryptocurrency Mining Processor line for 'professional mining 02/02/21 Tesla recalling 134,951 vehicles equipped with Nvidia Tegra 3 processor AMD AMD $86.41 / +1.9 (+2.25%) 02/01/21 Robinhood raises $3.4B to continue investing in customer growth 01/29/21 Robinhood updates limit on GameStop buys to one share, restricts other positions 01/17/21 Fly Intel: Top five weekend stock stories 01/12/21 AMD announces ful portfolio of AMD Ryzen 5000 Series mobile processors NVDA AMD NVDA Nvidia $553.84 / +5.03 (+0.92%) 02/25/21 Craig-Hallum Nvidia price target raised to $550 from $520 at Craig-Hallum 02/25/21 Needham Nvidia price target raised to $800 from $700 at Needham 02/25/21 Wedbush Nvidia price target raised to $640 from $600 at Wedbush 02/25/21 Truist Nvidia price target raised to $700 from $672 at Truist AMD AMD $86.41 / +1.9 (+2.25%) 01/29/21 Argus Xilinx downgraded to Hold from Buy at Argus 01/28/21 Citi AMD price target raised to $17 from $13 at Citi 01/27/21 JPMorgan AMD price target raised to $100 from $86 at JPMorgan 01/27/21 Craig-Hallum AMD price target raised to $120 from $100 at Craig-Hallum NVDA AMD NVDA Nvidia $553.84 / +5.03 (+0.92%) 02/24/21 Nvidia sees Q1 revenue $5.3B +/- 2%, consensus $4.51B 02/24/21 Nvidia reports Q4 EPS $3.10, consensus $2.81 02/24/21 Notable companies reporting after market close 11/18/20 Nvidia sees Q4 revenue $4.8B +/- 2%, consensus $4.42B AMD AMD $86.41 / +1.9 (+2.25%) 01/26/21 AMD sees FY21 revenue growth of approximately 37% 01/26/21 AMD sees Q1 revenue $3.2B, plus or minus $100M, consensus $2.73B 01/26/21 AMD reports Q4 EPS 52c, consensus 47c 01/26/21 Notable companies reporting after market close NVDA AMD NVDA Nvidia $553.84 / +5.03 (+0.92%) 02/12/21 Tech companies seek intervention in Nvidia acquisition of Arm, Bloomberg says 02/12/21 FTC opened in-depth investigation of Nvidia's ARM deal, Bloomberg reports 02/12/21 FTC investigating concerns over Nvidia's ARM acquisition, Bloomberg reports 02/12/21 Qualcomm expresses concern over Nvidia's $40B Arm takeover, CNBC reports AMD AMD $86.41 / +1.9 (+2.25%) 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/11/21 Biden administration called on by chip industry to fund factories, Reuters says 02/01/21 Robinhood in talks with lenders to raise $1B in debt, Reuters reports 01/27/21 AMD CEO sees PS5, Xbox part shortages continuing until 2H21, Gamespot says NVDA AMD NVDA Nvidia $553.84 / +5.03 (+0.92%) 02/26/21 The Intersection: Crypto and Wall Street This Week 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 02/24/21 Fly Intel: After-Hours Movers AMD AMD $86.41 / +1.9 (+2.25%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/26/21 The Intersection: Crypto and Wall Street This Week 02/19/21 The Intersection: Crypto and Wall Street This Week 02/12/21 The Intersection: Crypto and Wall Street This Week 04/12/21 NVIDIA Corp. NVDA AMD NVDA Nvidia $553.84 / +5.03 (+0.92%) 02/25/21 NVIDIA call buyer realizes 13% same-day gains 01/11/21 Early notable gainers among liquid option names on January 11th 11/18/20 NVIDIA options imply 8.0% move in share price post-earnings 11/04/20 NVIDIA call buyer realizes 8% same-day gains AMD AMD $86.41 / +1.9 (+2.25%) 02/09/21 Notable open interest changes for February 9th 01/27/21 Notable open interest changes for January 27th 01/26/21 Advanced Micro options imply 13.4% move in share price post-earnings 01/25/21 Notable open interest changes for January 25th
Periodicals	Uber spinning out delivery robot operation into startup, Bloomberg reports » 09:12 03/02/21 03/02 09:12 03/02/21 09:12 UBER Uber $54.40 / +2.6 (+5.02%) Uber Technologies is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options UBER Uber $54.40 / +2.6 (+5.02%) 02/26/21 EVgo says partnering to offer savings for EV drivers on Uber's platform 02/19/21 Uber to launch 'nationwide consultation' in UK after Supreme Court ruling 02/19/21 Uber drops 3% to $57.10 after U.K. Supreme Court rejects appeal 02/19/21 U.K. Supreme Court rejects Uber appeal, says drivers are workers UBER Uber $54.40 / +2.6 (+5.02%) 02/22/21 Loop Capital Airbnb upgraded to Buy from Hold at Loop Capital 02/17/21 Argus Uber price target raised to $73 from $63 at Argus 02/16/21 JMP Securities Uber price target raised to $75 from $58 at JMP Securities 02/12/21 DA Davidson Uber price target raised to $72 from $49 at DA Davidson UBER Uber $54.40 / +2.6 (+5.02%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/10/21 Uber reports Q4 EPS (54c), consensus (55c) 02/10/21 Notable companies reporting after market close 01/25/21 Fly Intel: What to watch in credit card space earnings reports 08 Jan UBER Uber $54.40 / +2.6 (+5.02%) 02/26/21 Uber-backed Lime in early talks to go public via a SPAC, BI reports 02/24/21 China's Didi Chuxing plans to make debut in Western Europe, Bloomberg says 02/18/21 Uber pushes 'work from home policy' out till mid-September, Tech Crunch reports 02/12/21 Uber would consider accepting bitcoin, CEO tells CNBC UBER Uber $54.40 / +2.6 (+5.02%) 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 02/12/21 The Intersection: Crypto and Wall Street This Week 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/11/21 Fly Intel: Wall Street's top stories at midday 03/05/21 Internet & New Media/Restaurants 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference UBER Uber $54.40 / +2.6 (+5.02%) 02/25/21 Uber call volume above normal and directionally bullish 02/10/21 Uber options imply 11.7% move in share price post-earnings 01/11/21 Uber call volume above normal and directionally bullish 01/07/21 Uber call volume above normal and directionally bullish

Hot Stocks	Tecogen announces sale of two InVerde cogeneration systems » 09:12 03/02/21 03/02 09:12 03/02/21 09:12 TGEN Tecogen $0.81 / + (+0.00%) Tecogen is pleased to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events TGEN Tecogen $0.81 / + (+0.00%) 10/15/20 Tecogen receives order for three Tecopower systems 10/08/20 Tecogen announces additional sales of TecoChill systems 10/06/20 Tecogen announces order for TecoChill air-cooled chiller 09/30/20 Tecogen announces order for Tecofrost refrigeration compressor TGEN Tecogen $0.81 / + (+0.00%) 03/13/20 H.C. Wainwright Tecogen price target lowered to $4.50 from $6 at H.C. Wainwright TGEN Tecogen $0.81 / + (+0.00%) 11/12/20 Tecogen reports Q3 EPS (1c), one est. (1c) 03/15/21 33rd Annual Roth Virtual Conference 03/11/21 Tecogen - TGEN
Hot Stocks	Humana unit Conviva acquires South Florida primary care physician network » 09:11 03/02/21 03/02 09:11 03/02/21 09:11 HUM Humana $384.60 / +5.04 (+1.33%) Conviva has announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events HUM Humana $384.60 / +5.04 (+1.33%) 03/01/21 Bio-Techne's Exosome Diagnostics laboratory announces contract with Humana 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/11/21 Humana, IBM Watson announce collaboration using artificial intelligence 02/03/21 Humana CEO sees 'solid growth in 2021 and beyond' HUM Humana $384.60 / +5.04 (+1.33%) 01/13/21 Deutsche Bank DaVita price target raised to $150 from $105 at Deutsche Bank 01/06/21 Argus Humana price target raised to $450 from $430 at Argus 01/04/21 Fly Intel: Top five analyst upgrades 01/04/21 Humana upgraded to Outperform at RBC Capital on above-average MA growth HUM Humana $384.60 / +5.04 (+1.33%) 02/03/21 Humana reports Q4 adjusted revenue $18.96B, consensus $18.77B 02/03/21 Humana sees FY21 adjusted EPS $21.25-$21.75, consensus $21.73 02/03/21 Humana reports Q4 adjusted EPS ($2.30), consensus ($2.36) 02/02/21 Notable companies reporting before tomorrow's open HUM Humana $384.60 / +5.04 (+1.33%) 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says HUM Humana $384.60 / +5.04 (+1.33%) 02/03/21 Fly Intel: Pre-market Movers 12/01/20 Fly Intel: What to watch in Salesforce's earnings report 11/14/20 Week in review: How Trump's policies moved stocks 00:00 Today 41st Annual Healthcare Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 10/06/21 Humana
Recommendations	Intercept price target lowered to $34 from $80 at Needham » 09:10 03/02/21 03/02 09:10 03/02/21 09:10 ICPT Intercept $21.68 / -0.04 (-0.18%) Needham analyst Joseph… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly ICPT Intercept $21.68 / -0.04 (-0.18%) 02/25/21 Intercept: FDA interactions 'ongoing' regarding NISS for liver disorder 02/25/21 Intercept sees FY21 Ocaliva net sales $325M-$355M 02/22/21 Intercept Chief Medical Officer Jason Campagna to resign 02/17/21 Intercept appoints Lisa DeFrancesco to executive leadership team ICPT Intercept $21.68 / -0.04 (-0.18%) 03/01/21 B. Riley Securities Intercept price target lowered to $65 from $74 at B. Riley Securities 03/01/21 Wedbush Intercept price target lowered to $88 from $106 at Wedbush 03/01/21 Chardan Intercept price target lowered to $45 from $58 at Chardan 02/23/21 H.C. Wainwright Intercept downgraded to Sell from Neutral at H.C. Wainwright ICPT Intercept $21.68 / -0.04 (-0.18%) 02/25/21 Intercept reports Q4 EPS ($1.58), consensus ($1.47) 11/09/20 Intercept narrows 2020 Ocaliva sales view $310-$320M from $300M-$320M 11/09/20 Intercept reports Q3 EPS ($2.01), consensus ($1.93) 18 Aug ICPT Intercept $21.68 / -0.04 (-0.18%) 10/08/20 FDA probes whether Intercept drug is tied to liver injury risk, STATNews reports ICPT Intercept $21.68 / -0.04 (-0.18%) 09/30/20 Before the Move: Watch Novo Nordisk, Bristol into AASLD abstract publication
Earnings	eXp World Holdings sees Q4 revenue $609M, consensus $521.8M » 09:10 03/02/21 03/02 09:10 03/02/21 09:10 EXPI eXp World Holdings $65.71 / +5.22 (+8.63%) Net income in the fourth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options EXPI eXp World Holdings $65.71 / +5.22 (+8.63%) 02/23/21 eXp World Holdings expands real estate operations into Brazil 02/09/21 Virbela, The Douglas Stewart Company partner for remote education 01/26/21 eXp World Holdings expands real estate operations into Puerto Rico 01/19/21 eXp World Holdings announces 2-for-1 stock split in form of a dividend EXPI eXp World Holdings $65.71 / +5.22 (+8.63%) 02/12/21 William Blair eXp downgraded to Market Perform on valuation at William Blair 02/12/21 William Blair eXp World Holdings downgraded to Market Perform from Outperform at William Blair 11/10/20 DA Davidson eXp World Holdings price target raised to $53 from $28 at DA Davidson 04/20/20 Stephens Stephens ups CoreLogic, downgrades two others in real estate services shake-up EXPI eXp World Holdings $65.71 / +5.22 (+8.63%) 11/09/20 eXp World Holdings reports Q3 EPS 20c, consensus 7c EXPI eXp World Holdings $65.71 / +5.22 (+8.63%) 09/28/20 eXp World Holdings named a short idea by PAA Research EXPI eXp World Holdings $65.71 / +5.22 (+8.63%) 01/19/21 Fly Intel: After-Hours Movers 10/23/20 Short-seller White Diamond calls eXp World Holdings 'massively overvalued' 03/08/21 eXp World Holdings EXPI eXp World Holdings $65.71 / +5.22 (+8.63%) 02/25/21 Largest borrow rate increases among liquid names 09/21/20 Largest borrow rate increases among liquid names
Conference/Events	Citigroup to hold a virtual event » 09:09 03/02/21 03/02 09:09 03/02/21 09:09 GMD Grupo Mexicano De Desarrollo $0.00 / + (+0.00%) , PLX Protalix $4.87 / + (+0.00%) Vietnam C-Suite Corporate… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events PLX PLX Protalix $4.87 / + (+0.00%) 02/23/21 Protalix, Chiesi announces results from BRIGHT clinical trial of PRX-102 02/11/21 Protalix announces license agreement with SarcoMed USA for PRX-110 02/10/21 Protalix's PRX-102 shows potential renal benefit in Phase 3 trial 12/30/20 Protalix provides pipeline update GMD PLX GMD Grupo Mexicano De Desarrollo $0.00 / + (+0.00%) PLX Protalix $4.87 / + (+0.00%) 12/31/20 H.C. Wainwright Protalix data underscore value proposition for PRX-102, says H.C. Wainwright 12 Feb PLX PLX Protalix $4.87 / + (+0.00%) 02/12/21 Fly Intel: Pre-market Movers 00:00 Today Vietnam C-Suite Corporate Virtual Day

Events

Earnings calls, analyst events, roadshows and more

Today at 10:00

COVID-19’s Effects on U.S. Aviation Government Event

Virtual Hearing
HMTV
Today at 10:00

Hemisphere Media - HMTV Conference Calls
EPZM
Today at 10:00

Epizyme - EPZM Conference Calls
FSKR
Today at 10:00

FS KKR Capital Corp. II - FSKR Conference Calls
TGLS
Today at 10:00

Tecnoglass - TGLS Conference Calls
AZO
Today at 10:00

AutoZone - AZO Conference Calls
PHX
Today at 10:00

PHX Minerals Inc Firm Sponsored Meetings
NDSN
Today at 10:00

Nordson Corp. Firm Sponsored Meetings
HLT ...
Today at 10:00

Software & Internet Industry Meetings
X
Today at 10:00

Metals & Mining Industry Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley $84.00-84.50 1.2M Shares RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 12M Shares OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $36.00-38.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: Wells Fargo, Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Lindblad Expeditions experiences 'substantial impact' from COVID-19

TODAY'S FREE FLY STORIES

Get Full Fly Access